4SC DISCOVERY GMBH has a total of 76 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2005. It filed its patents most often in New Zealand, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are XOC PHARMACEUTICALS INC, BOMBRUN AGNES and KUEHNERT SVEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | New Zealand | 9 | |
#2 | China | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Canada | 5 | |
#5 | United States | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 5 | |
#7 | Mexico | 4 | |
#8 | Singapore | 4 | |
#9 | Brazil | 3 | |
#10 | Hong Kong | 3 | |
#11 | Israel | 3 | |
#12 | Japan | 3 | |
#13 | Argentina | 2 | |
#14 | EAPO (Eurasian Patent Organization) | 2 | |
#15 | Republic of Korea | 2 | |
#16 | Taiwan | 2 | |
#17 | Ukraine | 2 | |
#18 | Uruguay | 2 | |
#19 | South Africa | 2 | |
#20 | Germany | 1 | |
#21 | United Kingdom | 1 | |
#22 | India | 1 | |
#23 | Montenegro | 1 | |
#24 | Malaysia | 1 | |
#25 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Leban Johann | 44 |
#2 | Zaja Mirko | 22 |
#3 | Tasler Stefan | 22 |
#4 | Chevrier Carine | 18 |
#5 | Saeb Wael | 18 |
#6 | Baumgartner Roland | 12 |
#7 | Kulkarni Sanjeev A | 9 |
#8 | Gekeler Volker | 9 |
#9 | Chaure Ganesh S | 8 |
#10 | Jagtap Anil P | 8 |
Publication | Filing date | Title |
---|---|---|
US2016137637A1 | 2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors | |
CA2854542A1 | Method of inhibiting dyrk1b | |
ZA201306087B | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation | |
US2012196862A1 | IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation | |
EP2668182A1 | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation | |
NZ593254A | Sulfamoyl- phenyl-ureido benzamidine-derivatives as antimalarial agents |